MedPath

Comparing the effect of albumin and crystalloid serum as resuscitation fluid in survival of patients with severe sepsis shock

Phase 3
Conditions
Septic shock.
Septic shock
Registration Number
IRCT2016040316473N5
Lead Sponsor
Vice chancellor for research, Tabriz University Of Medical Sciences.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

age between 12 to 75 years old; existence of at least two symptoms of SIRS syndrome (body temperature above 38 or below 36 ° C.; respiratory rate above 20 or PCO2 less than 32 or need for mechanical ventilation; heart rate more than 90, leukocytosis above 12,000 or leukopenia less than 4000 or band cells in peripheral blood smear); existence of a focal infection based on positive culture or existence of an obvious infected area such as peritonitis or pneumonia; need to resuscitation with fluid (tachycardia; systolic blood pressure less than 100 mm Hg or mean arterial pressure less than 75 mm Hg; urine volume less than 0.5 cc/kg/hr; need for vasopressor to maintain blood pressure; central venous pressure (CVP) less than 10 mm Hg).
Exclusion criteria: brain death patients; patients undergoing plasmapheresis; contraindications of albumin infusion; heart failure or pulmonary failure or renal failure; transplant patients; patients with burns; heart surgery at 3 recent months.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Survival of patients. Timepoint: Daily for 28 days. Method of measurement: clinical examination.
Secondary Outcome Measures
NameTimeMethod
Renal failure. Timepoint: Daily for 28 days. Method of measurement: Creatinine level.
© Copyright 2025. All Rights Reserved by MedPath